ARA-290
peptideevidence: emerging · v1Description
ARA-290 (cibinetide) is an 11-amino-acid research peptide derived from the helix-B region of erythropoietin. Studied in tissue-protection and metabolic research models. Lyophilized powder. Reconstitute with bacteriostatic water for in-vitro research. Store at -20°C. Certificate of Analysis attached to this listing.
Mechanism summary
(VEGF, nitric oxide, tendon healing), gut protection, musculoskeletal repair, oral vs injectable research, 2026 FDA reclassification status, safety profile, and clinical trial evidence for this gastric-derived healing peptide. Cognitive Enhancement Brain & Neuroprotection Semax Semax peptide guide: not FDA approved, but used in Russia since 2011. Covers BDNF upregulation, stroke recovery data, int [Source: Peptide Protocol Wiki]
Reference details
Route(s)
—
Tags
—
Active
yes
Product details · RA10
Price
$48.99
Stock
out of stock
Mol. weight
1257.4 g/mol
Purity
≥ 99%
CAS #
1208243-50-8
Amino sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (cibinetide)
COA: View certificate (batch TET-4897-A) →
Teton Labs product catalog · research-use compound data.
💉 Dosing — 1 reference (verbatim from source · not a recommendation)
Dose
4 mg
Route
subcutaneous or intranasal or oral
Frequency
Once daily
Duration
28 days
Source: Peptide Protocol Wiki (peptideprotocolwiki.com) (publication)Source-backedProvider-reviewed
Provider-only reference. This page does not constitute medical advice, a recommendation, or dosing guidance.